Latest Breaking News On - Company scientific advisory board - Page 3 : comparemela.com

Acurx Pharmaceuticals (ACXP) Granted FDA End of Phase 2 Meeting for Ibezapolstat for C difficile Infection

Acurx Pharmaceuticals (ACXP) Granted FDA End of Phase 2 Meeting for Ibezapolstat for C difficile Infection
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDavidp luciRobertj delucciaTrial oversight committeeAcurx pharmaceuticals incData monitoring committeeCompany scientific advisory boardEuropean medicines agency onDrug administrationAcurx pharmaceuticalsNew drug applicationMeeting requestMeeting packageBriefing documentEuropean medicines agencyScientific advice

Acurx Announces FDA Has Granted an End of Phase 2 Meeting for Ibezapolstat for C difficile Infection and the European Medicines Agency Granted SME Designation for Ibezapolstat EU Development

As previously announced, planning is underway with FDA to advance ibezapolstat into international Phase 3 clinical trials for treatment of C. difficile Infection As anticipated, an End of Phase 2.

United statesDavidp luciPrnewswire acurx pharmaceuticals incCompany scientific advisory boardAcurx pharmaceuticalsEuropean medicines agencyExchange commission on formSociety or healthcare epidemiology of americaDrug administrationData monitoring committeeInfectious diseases society of americaAcurx pharmaceuticals incTrial oversight committeeCompany phBriefing documentMedium sized enterprise

Karuna Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides General Business Update

Karuna Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides General Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMia kelleyJulie ciardielloAndrew millerAlexis smithSteve paulSecurities exchangeExchange commissionDrug administrationCompany karCompany scientific advisory boardKaruna therapeutics incBristol myers squibbCompany board of directorsNeuroscience education instituteNew drug application

Xenetic Biosciences, Inc Enters into Research Agreement with the University

Xenetic Biosciences, Inc. Enters into Research Agreement with the University .

Jeffrey eisenbergAllan tsungXenetic biosciencesResearch funding agreementXenetic biosciences incNews networkSchool of medicineCompany scientific advisory boardDepartment of surgeryResearch agreementCompany dnaseUniversity of virginiaMaterial transfer agreementScientific advisory boardChief executive officerLooking statements

Xenetic Biosciences (XBIO) Enters into Research Agreement with the University of Virginia for the Advancement of its DNase-Based Oncology Platform

Xenetic Biosciences (XBIO) Enters into Research Agreement with the University of Virginia for the Advancement of its DNase-Based Oncology Platform
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Jeffrey eisenbergAllan tsungXenetic biosciences incResearch funding agreementSchool of medicineDepartment of surgeryUniversity of virginiaCompany scientific advisory boardXenetic biosciencesMaterial transfer agreementScientific advisory boardChief executive officer